Genovis is a leading brand that specializes in developing and providing innovative tools for the biopharmaceutical and research industries. Their SmartEnzymes, known for their exceptional quality and performance, are widely utilized by scientists worldwide. These enzyme products are designed to streamline the process of developing new treatment methods and diagnostics, saving valuable time for researchers.

In addition to their enzyme products, Genovis offers an extensive range of antibodies, reagents, and services for use in research, biological drug development, and diagnostic assays. Their collaboration with academic groups ensures that they remain at the forefront of enzyme characterization, workflow development, and antibody production for novel targets. At Genovis, customer satisfaction is a priority, and they strive to meet the unique needs of their clients through strong customer relations and continuous product development.

The company is listed on Nasdaq First North Growth Market and operates through its main subsidiary, Genovis Inc., in the USA. With a commitment to quality and innovation, Genovis is dedicated to advancing scientific research and improving healthcare outcomes